Investing in the Future of Precision Cancer Medicine

Developing a first-in-class, 3rd generation Polo-like Kinase 1 (PLK1) Inhibitor to treat leukemias, lymphomas
and solid tumor cancers

Board Committees

Trovagene has the committees listed below in place.  The grid below provides an overview of the individuals that make up each committee.  To learn more about a particular committee or an individual member click the titles below.